Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:24:06 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:MYCOF from 2023-04-30 to 2024-04-29 - 25 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-25 18:46U:MYCOFNews ReleaseMydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order
2024-04-15 17:05U:MYCOFNews ReleaseMydecine Innovations Group Inc. Announces Closing Of Share For Debt Settlement
2024-04-08 16:06U:MYCOFNews ReleaseMydecine Innovations Group Inc. Announces Share for Debt Settlement
2024-03-27 19:01U:MYCOFNews ReleaseMydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement
2024-03-20 17:02U:MYCOFNews ReleaseMydecine Innovations Group Inc. Announces Share for Debt Settlement
2024-02-07 17:01U:MYCOFNews ReleaseMydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
2024-02-02 16:05U:MYCOFNews ReleaseMydecine Innovations Group Announces Director Resignation
2023-12-18 02:00U:MYCOFNews ReleaseMydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
2023-11-28 16:05U:MYCOFNews ReleaseMydecine Announces Update Regarding the Special Access Program
2023-10-31 02:00U:MYCOFNews ReleaseMydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
2023-10-26 02:00U:MYCOFNews ReleaseMydecine Provides Q4 2023 Business Update
2023-10-18 06:17U:MYCOFNews ReleaseMydecine Innovations Group gearing up for human trials after completing Aquis listing
2023-10-10 02:00U:MYCOFNews ReleaseMydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
2023-10-05 17:01U:MYCOFNews ReleaseMydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
2023-09-27 17:18U:MYCOFNews ReleaseMydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
2023-09-20 12:12U:MYCOFNews ReleaseMydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
2023-09-19 16:01U:MYCOFNews ReleaseMydecine Innovations Announces Closing of Prospectus Supplement Financing
2023-09-15 17:30U:MYCOFNews ReleaseMydecine Innovations Group Files Prospectus Supplement
2023-08-30 16:01U:MYCOFNews ReleaseMydecine Announces Conditional Approval of CSE Listing
2023-08-14 20:33U:MYCOFNews ReleaseMydecine Reports Financial Results for the Second Quarter of ‚  Fiscal Year 2023
2023-07-21 17:30U:MYCOFNews ReleaseMydecine Innovations Group Provides Corporate Update
2023-07-05 16:01U:MYCOFNews ReleaseMydecine Reports its Special Meeting Results
2023-05-29 19:42U:MYCOFNews ReleaseMydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
2023-05-16 16:01U:MYCOFNews ReleaseMydecine Reports Financial Results for the First Quarter of Fiscal Year 2023
2023-05-10 16:05U:MYCOFNews ReleaseMydecine Reports its 2023 Annual General Shareholders' Meeting Results